BioShares Biotechnology Clinical Trials ETF (BBC) ETF

Expense Ratio: 0.85% | AUM: 30.36M | Issuer: BioShares

BBC Daily Price Range
BBC 52-Week Price Range

BBC - Real-Time SMART Grade™

A
Strong Buy

Overall SMART Grade

BBC has a real-time SMART Grade of A (Strong Buy).

Learn More About SMART Grades™

BBC - Profile & Info


The investment objective of the Virtus LifeSci Biotech Clinical Trials ETF seeks investment results that correspond to the price and yield performance of the BioShares Biotechnology Clinical Trials Index. The clinical trials index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering that is in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development.

Issuer BioShares
Expense Ratio 0.85%
Assets Under Management (AUM) 30.36M
Underlying Index BioShares Biotechnology Clinical Trials Index
Asset Class Equity
ETF Category Health & Biotech ETFs
Net Asset Value (NAV) $28.91
Options? Yes
Total Holdings N/A

BBC - Top Stories


View All BBC News

BBC - Price/Volume Stats

Current price $28.70
Prev. close $28.92
Day low $28.66
Day high $29.14
52-week high $29.14
52-week low $16.33
Day Volume 9,095
Avg. volume 12,010
Dividend yield 0.00%

BBC - Recent Returns

1-mo 17.94%
3-mo 14.34%
6-mo 24.95%
1-year 25.44%
3-year N/A
5-year N/A
YTD 55.89%
2016 -36.63%
2015 5.25%
2014 N/A
2013 N/A
2012 N/A

BBC - Stock Chart


BBC - Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...

Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular Articles


From Our Partners


Page generated in 2.298 seconds.